Kansas lawmakers plan to legalize medical marijuana by 2023

Dec.14.2022
Kansas lawmakers plan to legalize medical marijuana by 2023
Medical marijuana legalization may become a reality in Kansas by 2023, with a new bill expected to be introduced.

The legalization of medical marijuana may become a reality in the state of Kansas in 2023.


Rob Olson, a Republican senator from Olathe and the chair of the 2022 Medical Marijuana Special Committee, announced during a committee meeting on December 9th that he plans to introduce legislation on medical marijuana in the Senate at the start of the 2023 legislative session.


Over the past few months, the committee has been holding a series of meetings to discuss drafting the 2023 Medical Marijuana Legalization Act and what improvements can be made from the failed legislation this year.


During this year's legislative session, Kansas made several attempts to legalize medical marijuana but ultimately failed. These included a medical marijuana proposal that was left pending in the Senate in May, a bill that was passed by the House but never received support in the Senate, and a Senate bill. According to a report by Cannabis Business Times, Senator Olson introduced a bill in March.


As reported by CBT, legislators held two hearings in October: one to hear testimony from law enforcement agencies, state agencies, and local governments, and another to hear testimony from the public on the issue at hand.


According to the Kansas Reflector, lawmakers discussed research on social equity, packaging and labeling, procurement restrictions, and local taxation during their most recent meeting on December 9th.


After a series of meetings, Olsen announced that he is planning to propose a bill to legalize medical marijuana to the Senate at the start of the legislative session in 2023.


I think what I need to do is warmly welcome any member to obtain this information and draft a bill," said Olsen. "I will work with several members to draft a bill, and if someone wants to sign the bill in the Senate, they will be able to do so and introduce it at the start of the meeting.


According to a news media report, Olsen also encouraged members of the House of Representatives who are part of the Medical Marijuana Special Committee to introduce a separate bill in their chamber.


The entire issue dates back to last year when we had a very strong bill pass in the House of Representatives, but Senate Majority Leader Ty Masterson did not allow it to move forward," said Senator Cindy Holscher of D-Overland Park. "I know that members of different political parties have been reaching out to remind him of how important this issue is to many different people. So, only time will tell what will happen.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation
Euromonitor: RRP Market Reaches $74 Billion, Accounting for 12.7% of Global Nicotine Industry as Five Key Trends Drive Transformation
In 2025, global tobacco leaf production surged, but prices stagnated as climate change intensified farming risks. 2Firsts reports from the ITGA meeting, revealing structural challenges and transition pressures in the industry.
Sep.29
Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Altria’s on!PLUS Nicotine Pouches Reportedly Available in U.S.; Users Say They Have Received Orders
Social media users reported purchasing Altria’s new nicotine pouch, on!PLUS, in the United States. 2Firsts found that the official on! website had temporarily opened online purchase and store locator functions. The product has not received FDA authorization. Around the same time, British American Tobacco (BAT) suspended its unlicensed Vuse One vape launch in the U.S. amid regulatory pressure.
Oct.28 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
JTI launches Ploom AURA new heated tobacco device device in Romania
JTI launches Ploom AURA new heated tobacco device device in Romania
Japan Tobacco International(JTI) introduces Ploom AURA in Romania, combining SMART HEATFLOW technology to preserve tobacco flavor, aiming at high-end consumers.
Oct.17 by 2FIRSTS.ai
STMA to Hold Hearing on License Leasing Case in Shenzhen
STMA to Hold Hearing on License Leasing Case in Shenzhen
The State Tobacco Monopoly Administration (STMA) announced a public hearing will be held on Nov. 11 at 9 a.m. in Bao’an District, Shenzhen, regarding Shenzhen Biaogan Zhizao Technology Co., Ltd. accused of leasing its tobacco retail license.
Oct.31 by 2FIRSTS.ai